Psilocybin as a Novel Therapy for Residual Anhedonia
Clinical trial NCT07607938 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07607938
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.